Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F08%3A4138" target="_blank" >RIV/00064203:_____/08:4138 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/08:4138
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?
Original language description
The ALL IC-BFM 2002 protocol was created as an alternative to the MRD-based AIEOP-BFM ALL 2000 study, to integrate early response criteria into risk-group stratification in countries not performing routine PCR-based MRD testing.
Czech name
Analýza minimální reziduální nemoci (MRN) u protokolu ALL IC-BFM 2002 pro léčbu dětské ALL: Je možné vyhnout se testování MRN?
Czech description
Analýza minimální reziduální nemoci (MRN) u protokolu ALL IC-BFM 2002 pro léčbu dětské ALL: Je možné vyhnout se testování MRN?

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
<a href="/en/project/NR8269" target="_blank" >NR8269: Polychromatic flow cytometry and regulation of aberrant expression from the perspective of Minimal Residual Disease</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year
2008
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)